Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2052693.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thirty-eight children with soft-tissue venous malformations (VMs) were treated with percutaneous injection of a new fibrosing agent (Ethibloc). The technique, results, side effects, and complications are detailed. Direct puncture of the VM allows evaluation of the draining venous system and direct injection of Ethibloc. This procedure alone or associated with surgery led to achievement of good or excellent results in 74% of the cases (complete cure in 50%), with minimal side effects and no major complications.
Medical subject headings
- Diatrizoate
- Fatty Acids
- Propylene Glycols
- Proteins
- Sclerotherapy
- Veins
- Zein